发明名称 CANNABINOID RECEPTOR LIGAND
摘要 <P>PROBLEM TO BE SOLVED: To provide a compound of general formula (I), to provide a method for producing such a compound, to provide a pharmaceutical prescribed product or pharmaceutical composition containing one or more such compounds, and to provide a method for preparing the pharmaceutical prescribed product or pharmaceutical composition. Ž<P>SOLUTION: The compound of formula (I) (for example, N-ä5-[2-(2-fluorophenylsulfonyl)-4-trifluoromethoxybenzoyl]indan-1-yl}trifluoromethylsulfonamide), or a pharmaceutically acceptable salt of the compound or a pharmaceutically acceptable solvate of the compound, is provided. The pharmaceutical composition containing the compound, which may be useful as a cannabinoid receptor ligand, may be used for treating cancer, inflammatory diseases, immunoregulatory diseases or respiratory disorders. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
申请公布号 JP2010059169(A) 申请公布日期 2010.03.18
申请号 JP20090247114 申请日期 2009.10.27
申请人 SCHERING CORP 发明人 TONG LING;CHEN LEI;SHANKAR BANDARPALLE B;KOZLOWSKI JOSEPH A;SHIH NENG-YANG
分类号 C07C317/32;A61K31/165;A61K31/18;A61K31/353;A61K31/4402;A61K31/4439;A61P1/04;A61P1/16;A61P3/10;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/04;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P27/06;A61P29/00;A61P35/00;A61P37/00;A61P37/02;A61P37/08;A61P43/00;C07C323/31;C07C323/41;C07C323/49;C07D213/71;C07D401/12 主分类号 C07C317/32
代理机构 代理人
主权项
地址